EEP Stock Overview
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Euroespes, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.34 |
| 52 Week High | €0.49 |
| 52 Week Low | €0.32 |
| Beta | 0.030 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -29.17% |
| 33 Year Change | -30.61% |
| 5 Year Change | -56.13% |
| Change since IPO | -88.36% |
Recent News & Updates
Shareholder Returns
| EEP | ES Life Sciences | ES Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | 1.5% |
| 1Y | -29.2% | 1.4% | 15.4% |
Return vs Industry: EEP underperformed the Spanish Life Sciences industry which returned -16.7% over the past year.
Return vs Market: EEP underperformed the Spanish Market which returned 7.5% over the past year.
Price Volatility
| EEP volatility | |
|---|---|
| EEP Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 3.0% |
| 10% most volatile stocks in ES Market | 5.6% |
| 10% least volatile stocks in ES Market | 0.6% |
Stable Share Price: EEP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EEP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 39 | Ramon Cacabelos Garcia | www.euroespes.com |
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology.
Euroespes, S.A. Fundamentals Summary
| EEP fundamental statistics | |
|---|---|
| Market cap | €3.67m |
| Earnings (TTM) | -€1.14m |
| Revenue (TTM) | €3.86m |
1.0x
P/S Ratio-3.2x
P/E RatioIs EEP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EEP income statement (TTM) | |
|---|---|
| Revenue | €3.86m |
| Cost of Revenue | €2.47m |
| Gross Profit | €1.38m |
| Other Expenses | €2.52m |
| Earnings | -€1.14m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 35.92% |
| Net Profit Margin | -29.49% |
| Debt/Equity Ratio | 68.3% |
How did EEP perform over the long term?
See historical performance and comparison